{BATOCLIMAB: A PROMISING NEW APPROACH FOR INFLAMMATORY BOWEL DISEASE?

Batoclimab, a new antibody aimed at the IL-15 receptor, is emerging as a significant medicinal option for individuals living with difficult-to-treat ulcerative colitis and haven't responded adequately to existing treatments. Early clinical data suggest that batoclimab can effectively alleviate in